Copyright
©The Author(s) 2021.
World J Stem Cells. May 26, 2021; 13(5): 439-451
Published online May 26, 2021. doi: 10.4252/wjsc.v13.i5.439
Published online May 26, 2021. doi: 10.4252/wjsc.v13.i5.439
Advantages | Disadvantages | |
ESCs | ||
High differentiation capability which can recapitulate appropriate cell-intrinsic phenotypes | Ethical dilemma | |
Grow up in the laboratory from a single cell for later transplantation | Tumorigenesis risk | |
MSCs | ||
Immunomodulatory properties | A narrower spectrum of differentiation | |
Widespread availability and accessibility | High expression of ACE2 receptor | |
Limited ethical concerns | Expression of MHC I and II |
- Citation: Mata-Miranda MM, Sanchez-Brito M, Vazquez-Zapien GJ. Different kinds of stem cells in the development of SARS-CoV-2 treatments. World J Stem Cells 2021; 13(5): 439-451
- URL: https://www.wjgnet.com/1948-0210/full/v13/i5/439.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i5.439